dr. eskelund on outcomes of tp53-mutated mcl
Published 6 years ago • 384 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
1:31
dr. eskelund on study of tp53 mutations in mantle cell lymphoma
-
1:28
dr. eskelund discusses tp53 mutated mantle cell lymphoma
-
2:13
dr. rule on patients with p53-mutated mcl
-
1:49
dr. shah on treatment of patients with p53-mutated mcl
-
2:42
challenges in treating patients with tp53-mutated mcl & promising novel therapies being explored
-
1:56
dr. elhassadi discusses the outlook of patients with p53-mutated mcl
-
1:38
dr. shah discusses p53-mutated mantle cell lymphoma
-
1:15
dr. rule on treatment approaches for patients with p53-mutated mcl
-
1:36
the impact of tp53 mutation on treatment approaches in mcl
-
2:48
outcomes of autosct, allosct & car-t cell therapy in patients with tp53-altered mcl
-
3:56
treatment approaches for patients with tp53-mutated mcl
-
2:16
treating tp53 mutant mantle cell lymphoma in the boven trial
-
4:08
mantle cell lymphoma: impact of genetic variants
-
2:01
dr. elhassadi on the relationship between p53 expression and prognosis in mcl
-
3:54
zuma-2: outcomes of r/r mcl patients who progressed within 24 months of diagnosis
-
1:26
dr. miklos on the results of the zuma-2 trial in mcl
-
1:10
car-t therapy for high-risk mcl patients
-
1:23
dr. elhassadi on 10-year single-center experience with tp53 status in mcl
-
1:10
dr. wang on the toxicity of ibrutinib, acalabrutinib, and zanubrutinib in mcl